Table 1.

Selected baseline characteristics and changes in BMI and weight after 1 year of therapy for intensive and conventional treatment groups

	Adult women		Adult men
	Intensive	Conventional	Intensive	Conventional
n	302	278	317	349
Age (years)	29.0 ± 6.0	28.1 ± 5.9	29.5 ± 5.4	29.3 ± 5.3
Body weight (kg)	63.4 ± 8.6	63.5 ± 8.9	75.6 ± 9.7	78.1 ± 10.5*
Change at 1 year	3.0 ± 4.1†	1.1 ± 3.8†‡	3.6 ± 4.8†	1.3 ± 3.7†‡
Height (cm)	164.5 ± 6.2	165.2 ± 5.8	178.6 ± 6.7	178.9 ± 7.2
BMI (kg/m2)	23.4 ± 2.8	23.2 ± 2.9	23.7 ± 2.5	24.3 ± 2.6§
Change at 1 year	1.1 ± 1.6†	0.4 ± 1.4†‡	1.1 ± 1.5†	0.4 ± 1.2†‡
HbA1c (%)	9.0 ± 1.5	8.9 ± 1.7	8.6 ± 1.4	8.6 ± 1.5
Duration of type 1 diabetes (month)	72.3 ± 52.3	74.3 ± 52.7	74.8 ± 51.2	65.6 ± 47.5∥
Insulin dose (units · kg−1 · day−1)	0.63 ± 0.20	0.63 ± 0.21	0.63 ± 0.23	0.60 ± 0.20

Values are means ± SD. P values for group differences are from the Wilcoxon’s rank-sum test and were not significant at the 0.05 level except as noted.

^*P = 0.001

^†P < 0.0001

^‡P < 0.0001 for changes from baseline by the Wilcoxon’s signed-rank test

^§P = 0.0003

^∥P = 0.026.